Ignasi Canals Selected Research

tungstate

2/2009	A functional leptin system is essential for sodium tungstate antiobesity action.
12/2005	Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats.
10/2005	Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ignasi Canals Research Topics

Disease

4	Obesity 02/2009 - 10/2004
4	Body Weight (Weight, Body) 02/2009 - 10/2004
2	Insulin Resistance 10/2005 - 10/2004
1	Menorrhagia 04/2016
1	Weight Gain 10/2005

Drug/Important Bio-Agent (IBA)

3	tungstateIBA 02/2009 - 10/2005
2	Proteins (Proteins, Gene)FDA Link 12/2005 - 10/2004
1	Contraceptive Agents (Contraceptives)IBA 04/2016
1	sodium tungstate(VI) (sodium tungstate)IBA 02/2009
1	LeptinIBA 02/2009
1	Guanine DeaminaseIBA 12/2005
1	Transferrin (beta 2 Transferrin)IBA 12/2005
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 12/2005
1	VimentinIBA 12/2005
1	VinculinIBA 12/2005
1	Reducing AgentsIBA 12/2005
1	PeroxiredoxinsIBA 12/2005
1	Guanosine Triphosphate (GTP)IBA 12/2005
1	LipidsIBA 10/2005
1	S 23521IBA 10/2004
1	Glucose (Dextrose)FDA LinkGeneric 10/2004
1	Triglycerides (Triacylglycerol)IBA 10/2004
1	Glucagon (Glukagon)FDA Link 10/2004
1	AmidesIBA 10/2004

Therapy/Procedure

1	Transplantation 02/2009
1	Oral Administration 10/2005
1	Therapeutics 10/2005